120 related articles for article (PubMed ID: 8389993)
1. Neuroendocrine control of immunoreactive growth hormone and bioactive prolactin secretion in neonatal rats: ontogeny and interactions between the serotonergic, cholinergic and alpha 2-adrenergic systems.
Kacsóh B; Tóth BE; Grosvenor CE
Neuroendocrinology; 1993; 57(2):195-203. PubMed ID: 8389993
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Basal and nursing-induced secretion of growth hormone in the neonatal rat: the involvement of serotonergic, muscarinic cholinergic, alpha-adrenergic, somatostatin and growth hormone-releasing hormone systems.
Kacsóh B; Grosvenor CE
J Neuroendocrinol; 1991 Oct; 3(5):529-37. PubMed ID: 19215503
[TBL] [Abstract][Full Text] [Related]
3. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
[TBL] [Abstract][Full Text] [Related]
4. Interaction between norepinephrine and serotonin in the neuroendocrine control of growth hormone release in the rat.
Conway S; Richardson L; Speciale S; Moherek R; Mauceri H; Krulich L
Endocrinology; 1990 Feb; 126(2):1022-30. PubMed ID: 1688789
[TBL] [Abstract][Full Text] [Related]
5. Effect of 5-hydroxytryptophan on prolactin and growth hormone release in the infant rat: evidence for different neurotransmitter mediation.
Cocchi D; Gil-Ad I; Panerai AE; Locatelli V; Müller EE
Neuroendocrinology; 1977; 24(1):1-13. PubMed ID: 23503
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological manipulations of alpha-adrenoceptors in the infant rat and effects on growth hormone secretion. Study of the underlying mechanisms of action.
Cella SG; Locatelli V; De Gennaro V; Wehrenberg WB; Müller EE
Endocrinology; 1987 Apr; 120(4):1639-43. PubMed ID: 2881775
[TBL] [Abstract][Full Text] [Related]
7. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
Bero LA; Kuhn CM
J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
[TBL] [Abstract][Full Text] [Related]
8. Maternal modulation of growth hormone secretion in the neonatal rat. I. Involvement of milk factors.
Kacsoh B; Terry LC; Meyers JS; Crowley WR; Grosvenor CE
Endocrinology; 1989 Sep; 125(3):1326-36. PubMed ID: 2569390
[TBL] [Abstract][Full Text] [Related]
9. In vivo studies with growth hormone (GH)-releasing factor and clonidine in rat pups: ontogenetic development of their effect on GH release and synthesis.
Cella SG; Locatelli V; De Gennaro V; Pellini C; Pintor C; Müller EE
Endocrinology; 1986 Sep; 119(3):1164-70. PubMed ID: 3089765
[TBL] [Abstract][Full Text] [Related]
10. Interactions of histaminergic and serotonergic neurons in the hypothalamic regulation of prolactin and ACTH secretion.
Jørgensen H; Knigge U; Kjaer A; Warberg J
Neuroendocrinology; 1996 Nov; 64(5):329-36. PubMed ID: 8930933
[TBL] [Abstract][Full Text] [Related]
11. Maturation of central nervous system control of growth hormone secretion in rats.
Kuhn CM; Schanberg SM
J Pharmacol Exp Ther; 1981 Apr; 217(1):152-6. PubMed ID: 6970810
[TBL] [Abstract][Full Text] [Related]
12. Role of serotonin in opiate-induced prolactin secretion and antinociception in the developing rat.
Bero LA; Kuhn CM
J Pharmacol Exp Ther; 1987 Mar; 240(3):831-6. PubMed ID: 2435887
[TBL] [Abstract][Full Text] [Related]
13. Catecholaminergic regulation of opiate-stimulated growth hormone secretion in the developing rat.
Bero LA; Kuhn CM
J Pharmacol Exp Ther; 1986 Apr; 237(1):137-42. PubMed ID: 3007734
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical and pharmacological evidence for an intrinsic cholinomimetic system modulating prolactin and growth hormone release in rat pituitary.
Carmeliet P; Denef C
Endocrinology; 1988 Aug; 123(2):1128-39. PubMed ID: 3293981
[TBL] [Abstract][Full Text] [Related]
15. Mu- and kappa-opiate receptor control of prolactin secretion in rats: ontogeny and interaction with serotonin.
Blackford SP; Little PJ; Kuhn CM
Endocrinology; 1992 Dec; 131(6):2891-7. PubMed ID: 1332851
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of GH in maternal separation may be mediated through altered serotonergic activity at 5-HT2A and 5-HT2C receptors.
Katz LM; Nathan L; Kuhn CM; Schanberg SM
Psychoneuroendocrinology; 1996 Feb; 21(2):219-35. PubMed ID: 8774064
[TBL] [Abstract][Full Text] [Related]
17. Combined administration of growth-hormone-releasing hormone and clonidine restores defective growth hormone secretion in old dogs.
Cella SG; Arce VM; Pieretti F; Locatelli V; Settembrini BP; Müller EE
Neuroendocrinology; 1993 Mar; 57(3):432-8. PubMed ID: 8321415
[TBL] [Abstract][Full Text] [Related]
18. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
Mota A; Bento A; Peñalva A; Pombo M; Dieguez C
J Clin Endocrinol Metab; 1995 Jun; 80(6):1973-7. PubMed ID: 7775648
[TBL] [Abstract][Full Text] [Related]
19. Evidence for alpha-adrenergic regulation of episodic growth hormone and prolactin secretion in the undisturbed male rat.
Terry LC; Martin JB
Endocrinology; 1981 May; 108(5):1869-73. PubMed ID: 6260466
[TBL] [Abstract][Full Text] [Related]
20. Different serotonin receptor types participate in 5-hydroxytryptophan-induced gonadotropins and prolactin release in the female infantile rat.
Lacau-Mengido IM; Libertun C; Becú-Villalobos D
Neuroendocrinology; 1996 May; 63(5):415-21. PubMed ID: 8738578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
